Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 8, Pages 248
Publisher
MDPI AG
Online
2018-07-28
DOI
10.3390/cancers10080248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
- (2018) E E Vokes et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase
- (2018) Dana M. Gwinn et al. CANCER CELL
- c-RAF Ablation Induces Regression of Advanced Kras/Trp 53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling
- (2018) Manuel Sanclemente et al. CANCER CELL
- PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
- (2018) Mami Morita et al. CANCER CELL
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
- (2018) Michael K. Asiedu et al. CLINICAL CANCER RESEARCH
- Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing
- (2018) Charles Ricordel et al. Clinical Lung Cancer
- Spatial-Temporal Lineage Restrictions of Embryonic p63 + Progenitors Establish Distinct Stem Cell Pools in Adult Airways
- (2018) Ying Yang et al. DEVELOPMENTAL CELL
- Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
- (2018) Jason J. Luke et al. JOURNAL OF CLINICAL ONCOLOGY
- Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer
- (2018) Benjamin J. Solomon et al. JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Yi-Long Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
- (2018) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- (2018) Hira Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
- (2018) Naoko Imanishi et al. JOURNAL OF SURGICAL ONCOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. Journal of Thoracic Oncology
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- (2018) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- (2018) Kentaro Tanaka et al. LUNG CANCER
- SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
- (2018) Leila Dardaei et al. NATURE MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis
- (2018) Qibiao Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells
- (2018) Ahmad N. Nabhan et al. SCIENCE
- The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors
- (2018) Min He et al. Translational Oncology
- Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients
- (2018) Cheng Wang et al. Nature Communications
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
- (2018) Julie George et al. Nature Communications
- Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
- (2018) Benjamin J. Drapkin et al. Cancer Discovery
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation
- (2018) Qiwang Ma et al. Protein & Cell
- Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
- (2018) Shaohua Cui et al. Journal of Cancer
- The benefit and risk of nivolumab in non-small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials
- (2018) Binghao Zhao et al. Cancer Medicine
- Immunotherapy in surgically resectable non-small cell lung cancer
- (2018) Dwight Owen et al. Journal of Thoracic Disease
- Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
- (2018) Chia-Chi Lin et al. Lancet Respiratory Medicine
- Treatment of Advanced Non–Small Cell Lung Cancer in 2018
- (2018) Deborah B. Doroshow et al. JAMA Oncology
- Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Laura Mezquita et al. JAMA Oncology
- Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma
- (2018) Chee Khoon Lee et al. JAMA Oncology
- Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor
- (2018) William J. Zacharias et al. NATURE
- Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity
- (2017) Frances K. Turrell et al. GENES & DEVELOPMENT
- Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
- (2017) Ramaswamy Govindan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)
- (2017) Solange Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
- (2017) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
- (2017) Lucia Nogova et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses
- (2017) Tony S.K. Mok et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
- (2017) Ha Youn Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance)
- (2017) Arnaud Augert et al. Journal of Thoracic Oncology
- OA05.01 Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer: Updated Survival Results from KEYNOTE-028
- (2017) Patrick Ott et al. Journal of Thoracic Oncology
- Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer
- (2017) Xiaomei Gong et al. Journal of Thoracic Oncology
- Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
- (2017) Hawazin Faruki et al. Journal of Thoracic Oncology
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- (2017) Toyoaki Hida et al. LANCET
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
- (2017) Matthew D Hellmann et al. LANCET ONCOLOGY
- Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
- (2017) Julie R Brahmer et al. LANCET ONCOLOGY
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
- (2017) Narek Shaverdian et al. LANCET ONCOLOGY
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer
- (2017) Naomi Kobayashi-Watanabe et al. LUNG CANCER
- The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma
- (2017) Kazuki Takada et al. LUNG CANCER
- Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
- (2017) Clare E. Weeden et al. MOLECULAR CANCER THERAPEUTICS
- Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
- (2017) Jharna Datta et al. MOLECULAR CANCER THERAPEUTICS
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
- (2017) Jing Shan Lim et al. NATURE
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Isolation and 3D expansion of multipotent Sox9+ mouse lung progenitors
- (2017) Massimo Nichane et al. NATURE METHODS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Krasmutant genetically engineered mouse models of human cancers are genomically heterogeneous
- (2017) Wei-Jen Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of epigenetics in lung cancer heterogeneity and clinical implication
- (2017) Nian Dong et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer
- (2017) Fidelis Andrea Flockerzi et al. VIRCHOWS ARCHIV
- Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer
- (2017) Sabina Berezowska et al. VIRCHOWS ARCHIV
- Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
- (2017) Haikuo Zhang et al. Nature Communications
- Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
- (2017) Ian P. Winters et al. Nature Communications
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism
- (2017) Claudia Fumarola et al. Oncotarget
- Role and regulation of Yap in KrasG12D-induced lung cancer
- (2017) Yaopan Mao et al. Oncotarget
- Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study
- (2017) Michaël Duruisseaux et al. Oncotarget
- Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
- (2017) Fabian Doerr et al. Scientific Reports
- Incidence and mortality of lung cancer: global trends and association with socioeconomic status
- (2017) Martin C. S. Wong et al. Scientific Reports
- Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
- (2017) Massimo Moro et al. Scientific Reports
- Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
- (2017) Mi-Sook Lee et al. Cancer Research and Treatment
- Prognostic value of PD-L1 expression in combination with CD8+ TILs density in patients with surgically resected non-small cell lung cancer
- (2017) Hui Yang et al. Cancer Medicine
- Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma
- (2017) Yang Zhang et al. Journal of Thoracic Disease
- Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
- (2017) Daiana D. Becker-Santos et al. EBioMedicine
- PD-L1 expression in lung adenosquamous carcinomas compared with the more common variants of non-small cell lung cancer
- (2017) Xiaohua Shi et al. Scientific Reports
- Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition
- (2017) Verena Tiran et al. Scientific Reports
- Clinical correlation of extensive-stage small-cell lung cancer genomics
- (2016) A. Dowlati et al. ANNALS OF ONCOLOGY
- Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
- (2016) Michela Serresi et al. CANCER CELL
- SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
- (2016) Giustina Ferone et al. CANCER CELL
- Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
- (2016) G. Paolo Dotto et al. CANCER CELL
- Early Events in the Molecular Pathogenesis of Lung Cancer
- (2016) H. Kadara et al. Cancer Prevention Research
- Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
- (2016) Sarah K. Denny et al. CELL
- Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
- (2016) Tomohiro Miyoshi et al. CLINICAL CANCER RESEARCH
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
- (2016) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
- (2016) Takaaki Tokito et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
- (2016) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D
- (2016) Michele Simbolo et al. JOURNAL OF PATHOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
- (2016) Keunchil Park et al. LANCET ONCOLOGY
- Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
- (2016) Emma M. Kerr et al. NATURE
- Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
- (2016) Yong Jia et al. NATURE
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape ofEGFR-,MYC-, andKras-driven genetically engineered mouse models of lung adenocarcinoma
- (2016) David G. McFadden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
- (2016) Nan Wu et al. Oncotarget
- Genetic alteration profiling of patients with resected squamous cell lung carcinomas
- (2016) Dan Tao et al. Oncotarget
- Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
- (2016) Qingbao Li et al. Oncotarget
- PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
- (2016) Francesco Passiglia et al. Oncotarget
- SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
- (2016) Takuya Fukazawa et al. Scientific Reports
- Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods
- (2016) Xiaohua Shi et al. Scientific Reports
- Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
- (2016) Hong In Yoon et al. Cancer Research and Treatment
- Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
- (2016) Nadine S. Jahchan et al. Cell Reports
- Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
- (2016) Ekaterina A. Semenova et al. Cell Reports
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
- (2016) Mark D. Borromeo et al. Cell Reports
- Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study
- (2016) Jianxin Shi et al. PLOS MEDICINE
- Rare SOX2 + Airway Progenitor Cells Generate KRT5 + Cells that Repopulate Damaged Alveolar Parenchyma following Influenza Virus Infection
- (2016) Samriddha Ray et al. Stem Cell Reports
- Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- YAP Promotes Malignant Progression ofLkb1-Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
- (2015) Wenjing Zhang et al. CANCER RESEARCH
- Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib
- (2015) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Lung Master Protocol (Lung-MAP)--A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
- (2015) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
- (2015) A. Drilon et al. CLINICAL CANCER RESEARCH
- Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
- (2015) Sehui Kim et al. EUROPEAN JOURNAL OF CANCER
- Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
- (2015) Ariel Lopez-Chavez et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer incidence and ambient air pollution in China: a spatial age–period cohort study 1990–2009
- (2015) Yuming Guo et al. LANCET
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
- (2015) Andrew B Sharabi et al. LANCET ONCOLOGY
- NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy
- (2015) C. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
- (2015) Maria Moksnes Bjaanaes et al. Molecular Oncology
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors
- (2015) Christine M. Fillmore et al. NATURE
- Telomere dysfunction causes alveolar stem cell failure
- (2015) Jonathan K. Alder et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
- (2015) Evgeny Izumchenko et al. Nature Communications
- Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma
- (2015) Chenguang Li et al. Scientific Reports
- A New Mouse Avatar Model of Non-Small Cell Lung Cancer
- (2015) Maria Veronica Russo et al. Frontiers in Oncology
- Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
- (2015) Xiao-Yang Wang et al. Oncotarget
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations
- (2014) Y. Bai et al. CANCER RESEARCH
- Activin Upregulation by NF- B Is Required to Maintain Mesenchymal Features of Cancer Stem-like Cells in Non-Small Cell Lung Cancer
- (2014) J. J. Wamsley et al. CANCER RESEARCH
- Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
- (2014) David G. McFadden et al. CELL
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling
- (2014) Manash K. Paul et al. Cell Stem Cell
- Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy
- (2014) H. W. Lee et al. CLINICAL CANCER RESEARCH
- Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
- (2014) A. Karlsson et al. CLINICAL CANCER RESEARCH
- Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity
- (2014) C. Brambilla et al. CLINICAL CANCER RESEARCH
- Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
- (2014) C. Shao et al. CLINICAL CANCER RESEARCH
- Lung development: orchestrating the generation and regeneration of a complex organ
- (2014) M. Herriges et al. DEVELOPMENT
- The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2
- (2014) Xia Xu et al. GENES & DEVELOPMENT
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Telomerase mutations in smokers with severe emphysema
- (2014) Susan E. Stanley et al. JOURNAL OF CLINICAL INVESTIGATION
- Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
- (2014) Xun Yuan et al. Journal of Hematology & Oncology
- Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas
- (2014) Rui Wang et al. Journal of Thoracic Oncology
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
- (2014) Matthew D Hellmann et al. LANCET ONCOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Alveolar progenitor and stem cells in lung development, renewal and cancer
- (2014) Tushar J. Desai et al. NATURE
- p63+Krt5+ distal airway stem cells are essential for lung regeneration
- (2014) Wei Zuo et al. NATURE
- Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury
- (2014) Andrew E. Vaughan et al. NATURE
- The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
- (2014) Peter M. K. Westcott et al. NATURE
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
- (2014) Luca Toschi et al. PLoS One
- Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens
- (2014) Tracy L. Leong et al. PLoS One
- ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
- (2014) A. Augustyn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
- (2014) J. Zhang et al. SCIENCE
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Activated Leukocyte Cell Adhesion Molecule (CD166): An “Inert” Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
- (2014) Michael Tachezy et al. STEM CELLS
- Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
- (2014) haichuan hu et al. OncoTargets and Therapy
- YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression
- (2014) Yijun Gao et al. Nature Communications
- A paracrine network regulates the cross-talk between human lung stem cells and the stroma
- (2014) E. Josue Ruiz et al. Nature Communications
- Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
- (2014) Lynnette Fernandez-Cuesta et al. Nature Communications
- A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population
- (2014) Shaodong Hong et al. Scientific Reports
- Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer
- (2014) Anandaroop Mukhopadhyay et al. Cell Reports
- Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps
- (2014) Marius Ilie et al. Cancer Medicine
- Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
- (2013) D Wu et al. BRITISH JOURNAL OF CANCER
- The Pivotal Role of IKKα in the Development of Spontaneous Lung Squamous Cell Carcinomas
- (2013) Zuoxiang Xiao et al. CANCER CELL
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
- (2013) R. G. Liao et al. CANCER RESEARCH
- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- Fgf10-positive cells represent a progenitor cell population during lung development and postnatally
- (2013) E. El Agha et al. DEVELOPMENT
- Type 2 alveolar cells are stem cells in adult lung
- (2013) Christina E. Barkauskas et al. JOURNAL OF CLINICAL INVESTIGATION
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
- (2013) William D. Travis et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
- (2013) Youngwook Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
- (2013) Sara M. Nolte et al. JNCI-Journal of the National Cancer Institute
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers
- (2013) Jamie E. Chaft et al. Journal of Thoracic Oncology
- Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization
- (2013) Willam Sterlacci et al. Journal of Thoracic Oncology
- Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
- (2013) Xu-chao Zhang et al. Journal of Translational Medicine
- Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
- (2013) Ole Raaschou-Nielsen et al. LANCET ONCOLOGY
- HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
- (2013) Madhu S. Kumar et al. NATURE
- 50-Year Trends in Smoking-Related Mortality in the United States
- (2013) Michael J. Thun et al. NEW ENGLAND JOURNAL OF MEDICINE
- 21st-Century Hazards of Smoking and Benefits of Cessation in the United States
- (2013) Prabhat Jha et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation
- (2013) F Kosari et al. ONCOGENE
- Genomics of Squamous Cell Lung Cancer
- (2013) M. Rooney et al. ONCOLOGIST
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- NF-κB Regulates Mesenchymal Transition for the Induction of Non-Small Cell Lung Cancer Initiating Cells
- (2013) Manish Kumar et al. PLoS One
- Isolation of Cancer Stem Like Cells from Human Adenosquamous Carcinoma of the Lung Supports a Monoclonal Origin from a Multipotential Tissue Stem Cell
- (2013) Jennie P. Mather et al. PLoS One
- Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
- (2013) S. Mainardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells in lung cancer: Evidence and controversies
- (2013) Muhammad Alamgeer et al. RESPIROLOGY
- The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. THORAX
- MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
- (2013) O. A. Romero et al. Cancer Discovery
- Morphologic and Clinicopathologic Features of Lung Squamous Cell Carcinomas ExpressingSox2
- (2012) Luka Brcic et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer
- (2012) Anastasios Dimou et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities
- (2012) Dorian R.A. Swarts et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
- (2012) Shiwu Wu et al. BMC CANCER
- Therapeutic Effect of γ-Secretase Inhibition in KrasG12V-Driven Non-Small Cell Lung Carcinoma by Derepression of DUSP1 and Inhibition of ERK
- (2012) Antonio Maraver et al. CANCER CELL
- Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
- (2012) Ryan B. Corcoran et al. CANCER CELL
- Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446
- (2012) Xiaofei Qiu et al. CANCER LETTERS
- Mithramycin Represses Basal and Cigarette Smoke–Induced Expression ofABCG2and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
- (2012) Mary Zhang et al. CANCER RESEARCH
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
- (2012) Toshio Kubo et al. CANCER SCIENCE
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- (2012) Ramaswamy Govindan et al. CELL
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
- (2012) Wen Cai Zhang et al. CELL
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR-17-92 axis
- (2012) Feride Oeztuerk-Winder et al. EMBO JOURNAL
- Translating genomic information into clinical medicine: Lung cancer as a paradigm
- (2012) M. A. Levy et al. GENOME RESEARCH
- Recurrent inactivating mutations ofARID2in non-small cell lung carcinoma
- (2012) Gilles Manceau et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response
- (2012) Jaya Sangodkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- (2012) Jian-Mei Hou et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
- (2012) Kazuhiko Shien et al. LUNG CANCER
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- Smoking Induces Epithelial-to-Mesenchymal Transition in Non-Small Cell Lung Cancer through HDAC-Mediated Downregulation of E-Cadherin
- (2012) N. S. Nagathihalli et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells
- (2012) Yang Shi et al. PLoS One
- Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential
- (2012) Verline Justilien et al. PLoS One
- Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population
- (2012) Yi An et al. PLoS One
- KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients
- (2012) Albert D. Donnenberg et al. PLoS One
- Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development
- (2012) Chuwen Lin et al. PLoS One
- A framework for identification of actionable cancer genome dependencies in small cell lung cancer
- (2012) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma
- (2012) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
- (2012) S Akunuru et al. Cell Death & Disease
- Adenosquamous Carcinoma of the Lung
- (2011) Naobumi Tochigi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
- (2011) Kate D. Sutherland et al. CANCER CELL
- Identification of Tumorigenic Cells in KrasG12D-Induced Lung Adenocarcinoma
- (2011) H.-C. Cho et al. CANCER RESEARCH
- Notch-Dependent Differentiation of Adult Airway Basal Stem Cells
- (2011) Jason R. Rock et al. Cell Stem Cell
- Nuclear factor I/B is an oncogene in small cell lung cancer
- (2011) A. L. Dooley et al. GENES & DEVELOPMENT
- SOX2 amplification is a common event in squamous cell carcinomas of different organ sites
- (2011) Sebastian Maier et al. HUMAN PATHOLOGY
- Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
- (2011) Eugenia C. Pacheco-Pinedo et al. JOURNAL OF CLINICAL INVESTIGATION
- SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity
- (2011) Munehide Nakatsugawa et al. LABORATORY INVESTIGATION
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- (2011) Theresia Wilbertz et al. MODERN PATHOLOGY
- A crucial requirement for Hedgehog signaling in small cell lung cancer
- (2011) Kwon-Sik Park et al. NATURE MEDICINE
- Evidence for Human Lung Stem Cells
- (2011) Jan Kajstura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity
- (2011) Shailaja Akunuru et al. PLoS One
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
- (2011) Rita Mancini et al. PLoS One
- Matrix Metalloproteinase-10 Promotes Kras-Mediated Bronchio-Alveolar Stem Cell Expansion and Lung Cancer Formation
- (2011) Roderick P. Regala et al. PLoS One
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Progressive 3q Amplification Consistently TargetsSOX2in Preinvasive Squamous Lung Cancer
- (2010) Frank McCaughan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
- (2010) C D Salcido et al. BRITISH JOURNAL OF CANCER
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Presence of a Putative Tumor-Initiating Progenitor Cell Population Predicts Poor Prognosis in Smokers with Non-Small Cell Lung Cancer
- (2010) A. T. Ooi et al. CANCER RESEARCH
- Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells
- (2010) Stephen J. Curtis et al. Cell Stem Cell
- The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non-Small Cell Lung Cancer
- (2010) T. John et al. CLINICAL CANCER RESEARCH
- Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
- (2010) M. D. Wilkerson et al. CLINICAL CANCER RESEARCH
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
- (2010) Yihua Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- (2010) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
- (2010) J. Voortman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- Atypical Protein Kinase C Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
- (2009) R. P. Regala et al. CANCER RESEARCH
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
- (2009) V. Levina et al. CANCER RESEARCH
- Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
- (2009) M. Hussain et al. CANCER RESEARCH
- Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer
- (2009) T. Jiang et al. CANCER RESEARCH
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, Epithelium
- (2009) Emma L. Rawlins et al. Cell Stem Cell
- CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients
- (2009) Alexei V. Salnikov et al. INTERNATIONAL JOURNAL OF CANCER
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basal cells as stem cells of the mouse trachea and human airway epithelium
- (2009) J. R. Rock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer
- (2008) L A Frederick et al. ONCOGENE
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
- Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion
- (2008) J. S. Dovey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors
- (2007) Miten Patel et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started